Display options
Cite
Levi I, Feuchtwanger M, Rabinovich A, et al. Clinical and epidemiologic characteristics of non Hodgkin's lymphoma in Bedouins in the south of Israel. Springerplus. 2013;2:672doi: 10.1186/2193-1801-2-672.
Levi, I., Feuchtwanger, M., Rabinovich, A., & Grotto, I. (2013). Clinical and epidemiologic characteristics of non Hodgkin's lymphoma in Bedouins in the south of Israel. SpringerPlus, 2672. https://doi.org/10.1186/2193-1801-2-672
Levi, Itai, et al. "Clinical and epidemiologic characteristics of non Hodgkin's lymphoma in Bedouins in the south of Israel." SpringerPlus vol. 2 (2013): 672. doi: https://doi.org/10.1186/2193-1801-2-672
Levi I, Feuchtwanger M, Rabinovich A, Grotto I. Clinical and epidemiologic characteristics of non Hodgkin's lymphoma in Bedouins in the south of Israel. Springerplus. 2013 Dec 16;2:672. doi: 10.1186/2193-1801-2-672. eCollection 2013. PMID: 24386618; PMCID: PMC3874137.
Copy Download .nbib Format: NLM
Share it on

Springerplus. 2013 Dec 16;2:672. doi: 10.1186/2193-1801-2-672. eCollection 2013.

Clinical and epidemiologic characteristics of non Hodgkin's lymphoma in Bedouins in the south of Israel.

SpringerPlus

Itai Levi, Michal Feuchtwanger, Anat Rabinovich, Itamar Grotto

Affiliations

  1. Hematology Institute, Soroka University Medical Center, Beer-Sheva, Israel ; Department of Hematology, Soroka University Medical Center, PO Box 151, Beer-Sheva, Israel.
  2. Department of Family Medicine, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  3. Hematology Institute, Soroka University Medical Center, Beer-Sheva, Israel.
  4. Department of Epidemiology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

PMID: 24386618 PMCID: PMC3874137 DOI: 10.1186/2193-1801-2-672

Abstract

The presentation of Non Hodgkin's Lymphoma (NHL) may vary in relation to ethnicity or environmental effects. The objective of our study was to characterize NHL among the Negev Bedouin population, compared to the Jewish population. Retrospective data were collected for 45 Bedouin and 45 Jewish patients who were treated at Soroka University Medical Center between 1990 and 2007. Upon diagnosis, rates of aggressive NHL types, involvement of extra-lymphatic organs, as well as mean LDH were higher among Bedouin. Treatment response was poorer among the Bedouin: overall survival and disease-free survival were higher among Jews (mean of 145 and 168 months, respectively, compared with 70 and 45 months, respectively, among Bedouin; p < 0.01 for both). In summary, disease aggressiveness and poor response to treatment among the Negev Bedouin may shed some light on the pathogenicity of NHL and may indicate a need for more aggressive treatment in different ethnic groups.

Keywords: Bedouins; Epidemiology; Non Hodgkin’s lymphoma; Prognosis

References

  1. Isr Med Assoc J. 2000 Jul;2(7):501-3 - PubMed
  2. Ann Oncol. 2002 Jan;13(1):140-9 - PubMed
  3. Saudi Med J. 2004 May;25(5):609-14 - PubMed
  4. J Surg Oncol. 1989 Apr;40(4):241-4 - PubMed
  5. Acta Oncol. 2001;40(5):660-4 - PubMed
  6. Ann Hematol. 2010 Feb;89(2):179-84 - PubMed
  7. N Engl J Med. 1993 Sep 30;329(14):987-94 - PubMed
  8. Nutr Metab Cardiovasc Dis. 2001 Aug;11(4 Suppl):66-9 - PubMed
  9. Ethn Dis. 2008 Winter;18(1):13-8 - PubMed
  10. J Clin Oncol. 1999 Apr;17(4):1244 - PubMed
  11. Haematologica. 2005 Dec;90(12):1709-10 - PubMed
  12. CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66 - PubMed
  13. Isr Med Assoc J. 2007 Sep;9(9):652-5 - PubMed
  14. J Eur Acad Dermatol Venereol. 2008 Nov;22(10):1178-83 - PubMed

Publication Types